The Effects of Psilocybin on Self-Focus and Self-Related Processing in Major Depressive Disorder

Phase 3 Recruiting 20 enrolled Sharmin Ghaznavi COMPASS Pathways · collab

NaSingle-groupOpen-labelTreatment

Summary

This open-label functional Magnetic Resonance Imaging (fMRI) study will assess the effects of a single dose of psilocybin on rumination and the neural correlates of rumination in individuals with major depressive disorder.

Timeline

Start: 2024-09-10
Primary completion: 2028-06-30
Completion: 2028-06-30

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Psilocybin	Other / unclassified	25 mg	—

The Effects of Psilocybin on Self-Focus and Self-Related Processing in Major Depressive Disorder

Summary

Timeline

Drugs

Indications